Stock Analysis on Net

Abbott Laboratories (NYSE:ABT) 

Enterprise Value (EV)

Microsoft Excel

Current Enterprise Value (EV)

Abbott Laboratories, current enterprise value calculation

Microsoft Excel
Current share price (P) $130.82
No. shares of common stock outstanding 1,734,323,411
US$ in millions
Common equity (market value)1 226,884
Add: Preferred shares, one dollar par value, none issued (per books)
Add: Noncontrolling interests in subsidiaries (per books) 237
Total equity 227,121
Add: Short-term borrowings (per books)
Add: Current portion of long-term debt (per books) 1,500
Add: Long-term debt, excluding current portion (per books) 12,625
Total equity and debt 241,246
Less: Cash and cash equivalents 7,616
Less: Investments, primarily bank time deposits and U.S. treasury bills 351
Enterprise value (EV) 233,279

Based on: 10-K (reporting date: 2024-12-31).

1 Common equity (market value) = Share price × No. shares of common stock outstanding
= 130.82 × 1,734,323,411


Historical Enterprise Value (EV)

Abbott Laboratories, EV calculation

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Share price1, 2 $134.92 $114.01 $106.74 $116.79 $123.04
No. shares of common stock outstanding1 1,734,323,411 1,735,184,289 1,737,946,233 1,763,482,267 1,771,529,358
US$ in millions
Common equity (market value)3 233,995 197,828 185,508 205,957 217,969
Add: Preferred shares, one dollar par value, none issued (book value)
Add: Noncontrolling interests in subsidiaries (book value) 237 224 219 222 219
Total equity 234,232 198,052 185,727 206,179 218,188
Add: Short-term borrowings (book value) 213
Add: Current portion of long-term debt (book value) 1,500 1,080 2,251 754 7
Add: Long-term debt, excluding current portion (book value) 12,625 13,599 14,522 17,296 18,527
Total equity and debt 248,357 212,731 202,500 224,229 236,935
Less: Cash and cash equivalents 7,616 6,896 9,882 9,799 6,838
Less: Investments, primarily bank time deposits and U.S. treasury bills 351 383 288 450 310
Enterprise value (EV) 240,390 205,452 192,330 213,980 229,787

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 Data adjusted for splits and stock dividends.

2 Closing price as at the filing date of Abbott Laboratories Annual Report.

3 2024 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= 134.92 × 1,734,323,411

Item Description The company
EV Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments. Abbott Laboratories EV increased from 2022 to 2023 and from 2023 to 2024.